Skip to main content

Feb 12th Webinar: Denali Transport Vehicle (TV) Technology: DNL310 (ETV:IDS) Ph1/2 Cohort A Interim Data in Hunter Syndrome Patients

Denali Therapeutics
  • Home
  • Scientific Approach
    • Genetic Pathway Potential
    • Engineering Brain Delivery
    • Biomarker-Driven Development
    • Publications
  • Pipeline
  • Patients
  • Investor & Media Relations
    • Press Releases
    • Events
    • SEC Filings
    • Corporate Governance
    • Analyst Coverage
  • Leadership
  • Partnering
  • Careers
  • Contact

 

Contact Us

161 Oyster Point Blvd.
South San Francisco, CA
94080

 

By clicking submit you agree to our terms of service and privacy policy.

Join Us

CONTACT US

161 Oyster Point Blvd- South San Francisco, CA 94080

© 2022 Denali Therapeutics

  • Privacy Policy
  • Terms of Use

©2020 Denali Therapeutics | 161 Oyster Point Boulevard, South San Francisco, CA 94080

  • Privacy Policy
  • Terms of Use